Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26606253 | 1.00 | PDK2 (0.36) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL24646886 | 1.00 | PDK2 (0.36) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL20822724 | 0.99 | PDK2 (0.37) | PDK2MAPTL3MBTL1 | |
| SCHEMBL20822638 | 0.99 | PDK2 (0.37) | PDK2MAPTL3MBTL1 | |
| SCHEMBL15713757 | 0.99 | PDK2 (0.37) | PDK2MAPTL3MBTL1 | |
| SCHEMBL25966775 | 0.99 | PDK2 (0.37) | PDK2MAPTL3MBTL1 | |
| SCHEMBL24647848 | 0.97 | PDK2 (0.35) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL24647986 | 0.96 | PDK2 (0.36) | PDK2KDM4EMAPTL3MBTL1 | |
| SCHEMBL15713763 | 0.96 | PDK2 (0.36) | PDK2KDM4EMAPTL3MBTL1 | |
| SCHEMBL24646867 | 0.96 | PDK2 (0.36) | PDK2KDM4EMAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210126200-A1 | ORGANIC COMPOUNDS AND ORGANIC LIGHT EMITTING DISPLAY DEVICE USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210126200-A1 | ORGANIC COMPOUNDS AND ORGANIC LIGHT EMITTING DISPLAY DEVICE USING THE SAME | AOX1, OCIAD1, SLCO2A1 | PDK2 2383/4885KDM4E 3422/4885ALDH1A1 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.